Accuray to Participate in the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017

February 13, 2017 at 7:30 AM EST

SUNNYVALE, Calif., Feb. 13, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Kevin Waters, Senior Vice President and Chief Financial Officer, is scheduled to meet with investors one-on-one at the 2017 RBC Capital Markets Healthcare Conference in New York on Wednesday, February 22, 2017.   

Attendance at the conference is by RBC Capital Markets invitation only. The investor presentation used at the conference will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors on February 22, 2017.

About Accuray

Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives.  The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.  For more information, please visit www.accuray.com

Contacts:


Investors:

Brian Moore, EVC Group, 310-770-0389 (bmoore@evcgroup.com)

Doug Sherk, EVC Group, 415-652-9100 (dsherk@evcgroup.com)


Media:

Beth Kaplan

Public Relations Director, Accuray

408-789-4426

bkaplan@accuray.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-participate-in-the-2017-rbc-capital-markets-healthcare-conference-on-february-22-2017-300406034.html

SOURCE Accuray Incorporated